1. Home
  2. AZTR vs CMCT Comparison

AZTR vs CMCT Comparison

Compare AZTR & CMCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Azitra Inc

AZTR

Azitra Inc

HOLD

Current Price

$0.28

Market Cap

3.2M

Sector

Health Care

ML Signal

HOLD

Logo Creative Media & Community Trust Corporation

CMCT

Creative Media & Community Trust Corporation

HOLD

Current Price

$3.55

Market Cap

2.8M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
AZTR
CMCT
Founded
2014
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
3.2M
2.8M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
AZTR
CMCT
Price
$0.28
$3.55
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
315.9K
3.9M
Earning Date
11-12-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$113,028,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.26
$2.56
52 Week High
$4.33
$73.68

Technical Indicators

Market Signals
Indicator
AZTR
CMCT
Relative Strength Index (RSI) 36.30 44.76
Support Level $0.27 $3.44
Resistance Level $0.33 $5.08
Average True Range (ATR) 0.03 0.58
MACD 0.00 0.07
Stochastic Oscillator 14.52 31.38

Price Performance

Historical Comparison
AZTR
CMCT

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

About CMCT Creative Media & Community Trust Corporation

Creative Media & Community Trust Corp is formed to invest in, own, and operate Class A and creative office investments in improving urban communities throughout the United States. It operates through segments such as office, hotel and multifamily properties and lending. The Office segment includes rental of office space and other tenant services, including tenant reimbursements, parking, and storage space rental. The Hotel segment relates to operations of hotel properties whereas, the lending segment refers to income from the yield and other related fee income earned on its loans receivable. The lending segment includes income recognized from the sale of government guaranteed portion of loans receivable, income from the yield on its loans receivable and other related fee income earned.

Share on Social Networks: